Evaluation of gastric ulcerogenic and healing impairment effects of bisphosphonates: Adverse gastric reactions of bisphosphonate

Current Protocols in Toxicology

Volumn 1, Issue SUPPL.53, 2012, Pages

  Takeuchi, Koji ^a   Amagase, Kikuko ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Antral ulceration; Bisphosphonate; Gastric adverse effect; Healing impairment action

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CYCLOOXYGENASE 2; FIBROBLAST GROWTH FACTOR 2; GLUTATHIONE; INDOMETACIN; MESSENGER RNA; MINODRONIC ACID; MYELOPEROXIDASE; PROSTAGLANDIN E2; RISEDRONIC ACID; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; VASCULOTROPIN; BONE DENSITY CONSERVATION AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; ENZYME ACTIVITY; GENE EXPRESSION; HEALING IMPAIRMENT; LIPID PEROXIDATION; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; PROTEIN EXPRESSION; RAT; STOMACH ACID SECRETION; STOMACH LESION; STOMACH ULCER; ANIMAL; BIOASSAY; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG EFFECT; METHODOLOGY; PATHOLOGY; SPRAGUE DAWLEY RAT; STOMACH ANTRUM; WOUND HEALING;

ANIMALIA; RATTUS;

ANIMALS; BIOLOGICAL ASSAY; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; DISEASE MODELS, ANIMAL; MALE; PYLORIC ANTRUM; RATS; RATS, SPRAGUE-DAWLEY; STOMACH ULCER; WOUND HEALING;

EID: 84868094056     PISSN: 19349254     EISSN: 19349262     Source Type: Journal    
DOI: 10.1002/0471140856.tx2110s53     Document Type: Article

References (42)

1. Aihara, E., Hayashi, S., Amagase, K., Kato, S., and Takeuchi, K. 2007. Prophylactic effect of rebamipide against the irritative and healing impairment actions of alendronate in rat stomachs. Inflammopharmacology 15:196-202.
2. Amagase, K., Hayashi, S., Nishikawa, K., Aihara, E., and Takeuchi, K. 2007. Impairment of gastric ulcer healing by alendronate, a nitrogencontaining bisphosphonate, in rats. Dig. Dis. Sci. 52:1879-1889.
3. Amagase, K., Inaba, A., Senta, T., Ishikawa, Y., Nukui, N., Murakami, T., and Takeuchi, K. 2011. Gastric ulcerogenic and healing impairment effects of risedronate, a nitrogencontaining bisphosphonate, in rats: Comparison with alendronate and minodronate. J. Physiol. Pharmacol. 62:609-618.
4. Chen, S.H., Pan, S., Okita, K., and Takemoto, T. 1993. Role of superoxide dismutase in mechanism of diethyldithiocarbamate-induced gastric antral ulcer in rats: Protective effect of prostaglandin, cimetidine and pirenzepine. J. Gastroenterol. Hepatol. 8:457-461.
5. Donovan, J. and Brown, P. 2006. Parenteral injections. Curr. Protoc. Immunol. 73:1.6.1-1.6.10.
6. Elliott, S.N., McKnight, W., Davies, N.M., Mac-Naughton, W.K., and Wallace, J.L. 1998. Alendronate induces gastric injury and delays ulcer healing in rodents. Life Sci. 62:77-91.
7. Ernst, H., Konturek, P.C., Hahn, E.G., Stosiek, H.P., Brzozowski, T., and Konturek, S.J. 2001. Effect of local injection with basic fibroblast growth factor (bFGF) and neutralizing antibody to bFGF on gastric ulcer healing, gastric secretion, angiogenesis and gastric blood flow. J. Physiol. Pharmacol. 52:377-390.
8. Feng, L., Sun, W., Xia, Y., Tang, W.W., Chanmugam, P., Soyoola, E., Wilson, C.B., and Hwang, D. 1993. Cloning two isoforms of rat cyclooxygenase: Differential regulation of their expression. Arch. Biochem. Biophys. 307:361-368.
9. Folkman, J., Szabo, S., Stovroff, M., Mcneil, N., Li, W., and Shing, Y. 1991. Duodenal ulcer. Discovery of a new mechanism and development of angiogenic therapy that accelerates healing. Ann. Surg. 214:414-425.
10. Futaki, N., Takahashi, S., Yokoyama, M., Arai, I., Higuchi, S., and Otomo, S. 1994. NS-398, a new antiinflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclo-oxygenase (COX-2) activity in vitro. Prostaglandins 47:55-59.
11. Gallagher, S., Winston, S.E., Fuller, S.A. and Hurrell, J.G.R. 2008. Immunoblotting and immunodetection. Curr. Protoc. Mol. Biol. 83:10.8.1-10.8.28.
12. Graham, D.Y. 2002. What the gastroenterologist should know about the gastrointestinal safety profiles of bisphosphonates. Dig. Dis. Sci. 47:1665-1678.
13. Hatazawa, R., Tanaka, A., Tanigami, M., Amagase, K., Kato, S., Ashida, Y., and Takeuchi, K. 2007. Cyclooxygenase-2/prostaglandin E2 accelerates the healing of gastric ulcers via EP4 receptors. Am. J. Physiol. 293:G788-G797.
14. Hofman, F. 2002. Immunohistochemistry. Curr. Protoc. Immunol. 49:21.4.1-21.4.23.
15. Inatomi, N., Ishihara, Y., and Okabe, S. 1979. Effects of anti-ulcer agents on thermal-cortisoneinduced ulcers in rats. Jpn. J. Pharmacol. 29:486-488.
16. Kanatsu, K., Aihara, E., Okayama, M., Kato, S, and Takeuchi, K. 2004. Mucosal irritative and healing impairment action of risedronate in rat stomachs: Comparisonwith alendronate. J.Gastroenterol. Hepatol. 19:512-520.
17. Kaplowitz, N., Kuhenkamp, J., Goldstein, J.L., and Reeve, J. 1980. Effect of salicylates and phenobarbital on hepatic glutathione in the rats. J. Pharmacol. Exp. Ther. 212:240-245.
18. Kaŕadi, O., Abdel-Salam, O.M., B́odis, B., and Ḿozsik, G. 1996. Preventive effect of atropine on indomethacin-induced gastrointestinal mucosal and vascular damage in rats. Pharmacology 52:46-55.
19. Katayama, S., Shionoya, H., and Ohtake, S. 1978. A new method for extraction of extravasated dye in the skin and the influence of fasting stress on passive cutaneous anaphylaxis in guinea pigs and rats. Microbiol. Immunol. 22:89-101.
20. Kolm, R., Komarov, S.A., and Shay, H. 1945. Experimental studies on the excretion of neutral red by the stomach. Gastroenterology 5:303-319.
21. Krawisz, J.E., Sharon, P., and Stenson, W.F. 1984. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity: Assessment of inflammation in rat and hamster models. Gastroenterology 87:1344-1350.
22. Lowe, C.E., Depew, T.W., Vanner, S.J., Paterson, W.G., and Meddings, J.B. 2000. Upper gastrointestinal toxicity of alendronate. Am. J.Gastroenterol. 95:634-640.
23. Marshall, J.K., Rainsford, K.D., James, C., and Hunt, R.H. 2000. A randomized controlled trial to assess alendronate-associated injury of the upper gastrointestinal tract. Aliment. Pharmacol. Ther. 14:1451-1457.
24. Mizuno, H., Sakamoto, C., Matsuda, K., Wada, K., Uchida, T., Noguchi, H., Akamatsu, T., and Kasuga, M. 1997. Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology 112:387-397.
25. Ogino, K., Hobara, T., Ishiyama, H., Yamasaki, K., Kobayashi, H., Izumi, Y., and Oka, S. 1992. Antiulcer mechanism of action of rebamipide, a novel antiulcer compound, on diethyldithiocarbamate-induced antral gastric ulcers in rats. Eur. J. Pharmacol. 212:9-13.
26. Ohashi, Y., Aihara, E., Takasuka, H., Takahashi, K., and Takeuchi, K. 2009. Antral ulcers induced by alendronate, a nitrogen-containing bisphosphonate, in rat stomachs: Prophylactic effect of rebamipide. J. Physiol. Pharmacol. 60:85-93.
27. Ohkawa, H., Ohishi, N., and Yagi, K. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95:351-358.
28. Perry, M.A., Wadhwa, S., Parks, D.A., Pickard, W., andGranger, D.N. 1986. Role of oxygen radicals in ischemia-induced lesions in the cat stomach. Gastroenterology 90:362-367.
29. Sukkar, S.G., Schenone, E., Foppiani, L., and Nobile, M.T. 2004. Experimental assessment of chemotherapy-induced early intestinal damage in colon cancer the lactulose-mannitol permeability test. Tumori 90:461-463.
30. Szabo, S., Vincze, A., Sandor, Z.S., and Gombos, Z. 1998. Vascular approach to gastroduodenal ulceration: New studies with endothelins and VEGF. Dig. Dis. Sci. 43:40S-45S.
31. Takeuchi, K., Furukawa, O., Nishiwaki, H., and Okabe, S. 1987. 16,16-dimethyl prostaglandin E2 aggravates gastric mucosal injury induced by histamine in rats: Possible role of the increased mucosal vascular permeability. Gastroenterology 93:1276-1286.
32. Takeuchi, K., Okada, M., Niida, H., and Okabe, S. 1989. Role of sulfhydryls in mucosal injury caused by ethanol: Relation to microvascular permeability, gastric motility and cytoprotection. J. Pharmacol. Exp. Ther. 48:836-841.
33. Takeuchi, K., Kato, S., and Amagase, K. 2011. Gastric ulcerogenic and healing impairment actions of alendronate, a nitrogen-containing bisphosphonate: Prophylactic effects of rebamipide. Curr. Pharm. Design 17:1602-1611.
34. Tanaka, A., Hase, S., Miyazawa, T., and Takeuchi, K. 2002. Up-regulation of COX-2 by inhibition of COX-1: A key to NSAID-Induced intestinal damage. J. Pharmacol. Exp. Ther. 300:754-761.
35. Tarnawski, A. 1993. Cellularmechanisms of gastric ulcer healing. In the stomach. (W. Domschke and S.J. Konturek, eds.) pp 177-192. Springer, New York.
36. Tarnawski, A. 2005. Cellular and molecularmechanisms of gastrointestinal ulcer healing. Dig. Dis. Sci. 50:S24-S33.
37. Tsuji, K. 1978. Pathogenesis of the gastric ulcer induced by the serosa and mucosa searing method (author's translation). Nihon Shokakibyo Gakkai Zasshi 75:607-620.
38. Ukawa, H., Yamakuni, H., Kato, S., and Takeuchi, K. 1998. Effects of cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal antiinflammatory drugs on gastric ulcerogenic and healing responses in experimental animals. Dig. Dis. Sci. 43:2003-2011.
39. Voytas, D. 2000. Agarose gel electrophoresis. Curr. Protoc. Mol. Biol. 51:10.4.1-10.4.8.
40. Wang, J.Y., Yamasaki, S., Takeuchi, K., and Okabe, S. 1989. Delayed healing of acetic acid- induced gastric ulcers in rats by indomethacin. Gastroenterology 96:393-402.
41. Watanabe, K. and Kuno, H. 1976. Effect of carbenoxolone sodium on the experimental gastric ulcers induced by reserpine or prednisolone in rats and on the thermocauterization in mice. Pharmacometrics 11:239-243.
42. Yamamoto, O., Okada, Y., and Okabe, S. 1984. Effects of a proton pump inhibitor, omeprazole, on gastric secretion and gastric and duodenal ulcers or erosions in rats. Dig Dis Sci. 29:394-401.